Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL). The US regulator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback